NMNodir Madrahimov

Nodir Madrahimov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nodir Madrahimov has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Central retinal artery occlusion in a patient with aortic valve papillary fibroelastoma: a case report

    by Fabian Kerwagen, Antony William, Nodir Madrahimov, Sabrina Strobel, Nils Petri

    Background: Cardiac papillary fibroelastoma are rare benign tumours of the endocardium, often arising from heart valves. Despite their benign histology, papillary fibroelastoma carry high embolic potential and can lead to ischaemic events. In contrast to stroke, ocular embolization including central retinal artery occlusion is a rather rare first manifestation. Case summary: We report a 61-year-old female with sudden painless monocular vision loss due to central retinal artery occlusion. Initial stroke and cardiovascular work-up revealed a very small floating mass (0.6 × 0.4 × 0.2 cm) on the aortic valve by transesophageal echocardiography. The patient underwent successful surgical excision, with histopathology confirming papillary fibroelastoma. Discussion: Central retinal artery occlusion as a primary manifestation of papillary fibroelastoma highlights the embolic potential of these tumours. Multimodality imaging, especially transesophageal echocardiography, is crucial in diagnosis. Even very small papillary fibroelastoma may cause devastating embolic events such as irreversible monocular blindness. Surgical excision is the treatment of choice to prevent recurrence.

  • Open Access

    Long-term outcomes of common carotid artery cannulation for elective aortic surgery—a follow-up study

    by Kiril Penov, Patrick Kohnle, Matz Andreas Haugen, Dejan Radakovic, Nodir Madrahimov, Khaled Machwart, Khaled Hamouda, Rainer Leyh, Constanze Bening

    Background: The selection of the cannulation site for elective aortic surgery is mostly an individual choice based on the surgeon’s experience and the surgical strategy. We evaluated the long-term outcomes of right common carotid artery (CCA) cannulation using a side graft to establish unilateral selective antegrade cerebral perfusion (uSACP). Methods: We reviewed the records of 343 patients who underwent elective ascending aortic or aortic arch surgery between 2013 and 2020. One hundred aortic procedures were performed using the right CCA as the sole arterial cannulation site under moderate hypothermic circulatory arrest (MHCA). Cross-validated least absolute shrinkage and selection operator (LASSO) and stepwise Cox regression were applied to model the effects of cannulation sites on adverse outcomes. Kaplan-Meier analysis compared mortality in the treatment group with that in the general population. Results: The mean patient age was 65.9±9.5 years (81% male). The mean MHCA temperature was 27.1±5.1 ℃, and the average uSACP duration was 13.6±7.7 minutes. The early mortality and stroke rates were 1% and 4%, respectively. After a median of 5.4 follow-up years, seven patients suffered stroke, with 92% survival at 6 years, similar to an age- and gender-matched general population (log-rank P=0.50). Multivariable analysis revealed that age at surgery was the only significant predictor of late stroke or death [hazard ratio (HR) =1.083; P=0.01; c-index 0.683). Control Doppler ultrasound examination after a median of 2.3 years found no evidence of injury or dissection of the right CCA. Conclusions: Cannulation of the right carotid artery is a safe, feasible, and practical adjunct technique for proximal aortic surgery that generates comparable short- and long-term results. Careful patient selection and techniques are essential to minimize risk.


  • Open Access

    Multiorgan recovery in a cadaver body using mild hypothermic ECMO treatment in a murine model

    by Nodir Madrahimov, Vitalii Mutsenko, Ruslan Natanov, Dejan Radaković, André Klapproth, Mohamed Hassan, Mathias Rosenfeldt, Florian Kleefeldt, Ivan Aleksic, Süleyman Ergün, et al.

    Background: Transplant candidates on the waiting list are increasingly challenged by the lack of organs. Most of the organs can only be kept viable within very limited timeframes (e.g., mere 4–6 h for heart and lungs exposed to refrigeration temperatures ex vivo). Donation after circulatory death (DCD) using extracorporeal membrane oxygenation (ECMO) can significantly enlarge the donor pool, organ yield per donor, and shelf life. Nevertheless, clinical attempts to recover organs for transplantation after uncontrolled DCD are extremely complex and hardly reproducible. Therefore, as a preliminary strategy to fulfill this task, experimental protocols using feasible animal models are highly warranted. The primary aim of the study was to develop a model of ECMO-based cadaver organ recovery in mice. Our model mimics uncontrolled organ donation after an “out-of-hospital” sudden unexpected death with subsequent “in-hospital” cadaver management post-mortem. The secondary aim was to assess blood gas parameters, cardiac activity as well as overall organ state. The study protocol included post-mortem heparin–streptokinase administration 10 min after confirmed death induced by cervical dislocation under full anesthesia. After cannulation, veno-arterial ECMO (V–A ECMO) was started 1 h after death and continued for 2 h under mild hypothermic conditions followed by organ harvest. Pressure- and flow-controlled oxygenated blood-based reperfusion of a cadaver body was accompanied by blood gas analysis (BGA), electrocardiography, and histological evaluation of ischemia–reperfusion injury. For the first time, we designed and implemented, a not yet reported, miniaturized murine hemodialysis circuit for the treatment of severe hyperkalemia and metabolic acidosis post-mortem. Results: BGA parameters confirmed profound ischemia typical for cadavers and incompatible with normal physiology, including extremely low blood pH, profound negative base excess, and enormously high levels of lactate. Two hours after ECMO implantation, blood pH values of a cadaver body restored from < 6.5 to 7.3 ± 0.05, pCO2 was lowered from > 130 to 41.7 ± 10.5 mmHg, sO2, base excess, and HCO3 were all elevated from below detection thresholds to 99.5 ± 0.6%, − 4 ± 6.2 and 22.0 ± 6.0 mmol/L, respectively (Student T test, p < 0.05). A substantial decrease in hyperlactatemia (from > 20 to 10.5 ± 1.7 mmol/L) and hyperkalemia (from > 9 to 6.9 ± 1.0 mmol/L) was observed when hemodialysis was implemented. On balance, the first signs of regained heart activity appeared on average 10 min after ECMO initiation without cardioplegia or any inotropic and vasopressor support. This was followed by restoration of myocardial contractility with a heart rate of up to 200 beats per minute (bpm) as detected by an electrocardiogram (ECG). Histological examinations revealed no evidence of heart injury 3 h post-mortem, whereas shock-specific morphological changes relevant to acute death and consequent cardiac/circulatory arrest were observed in the lungs, liver, and kidney of both control and ECMO-treated cadaver mice. Conclusions: Thus, our model represents a promising approach to facilitate studying perspectives of cadaveric multiorgan recovery for transplantation. Moreover, it opens new possibilities for cadaver organ treatment to extend and potentiate donation and, hence, contribute to solving the organ shortage dilemma.


  • Does Repeated Levosimendan Improve ECMO Weaning and Survival in Postcardiotomy ECMO Patients?

    by R. Natanov, N. Madrahimov, S. Rümke, B. Wiegmann, A. Haverich, C. Kühn

    Background: Postoperative mechanical circulatory support due to myocardial failure after cardiac surgery is a proven therapy of choice. Additional inotropic support generally improves hemodynamic stability, and the use of levosimendan has previously been associated with improved cardiac output in heart failure patients. Here, we investigate the effect of repeated levosimendan in patients on veno-arterial extracorporeal membrane oxygenation (va-ECMO) due to postcardiotomy myocardial failure. Method: All patients treated with va-ECMO due to postcardiotomy myocardial failure admitted to our cardiac surgery intensive care unit (ICU) were included in this study. Patients treated with levosimendan and patients without levosimendan treatment were compared. A subgroup population with patients treated repeatedly with levosimendan was analyzed to assess the outcome. Levosimendan was given intravenously over 24 hours and, when deemed needed, repeated during the patient's stay in the ICU. Retrospective analysis of ECMO runtime, need for inotropic and vasopressor agents, ventilator time, and the outcome was examined. Results: In total, 242 patients were treated with va-ECMO in our medical center due to postcardiotomy heart failure. The mean patient age was 58.8 ± 0.9 years. Coronary artery bypass surgery (74 patients; 30.6%), LVAD implantation (50 patients; 20.7%) and heart valve operations (46 patients; 19%) were the main causes for postcardiotomy heart failure. Levosimendan was given in 152 (62.8%) patients. In 72 patients (29.8%), the infusion of levosimendan was repeated during the ICU stay. When compared between patients treated with levosimendan and control patients, a significant improvement in successful ECMO weaning was seen. Overall survival was not improved after one-time levosimendan treatment. After repeated treatment, however, there was a significant improvement in survival in the levosimendan group. Conclusion: A single perioperative levosimendan treatment in patients on va-ECMO after postcardiotomy heart failure showed improved weaning rates; however, it did not improve survival. Patients treated with repeated levosimendan infusions showed a significant improvement in survival. We suggest a repeated infusion of levosimendan in patients on va-ECMO due to postcardiotomy syndrome. Article published online: 28 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Different Acute Kidney Injury Patterns after Renal Ischemia Reperfusion Injury and Extracorporeal Membrane Oxygenation in Mice

    by Robert Greite, Johanna Störmer, Faikah Gueler, Rasul Khalikov, Axel Haverich, Christian Kühn, Nodir Madrahimov, Ruslan Natanov

    The use of extracorporeal membrane oxygenation (ECMO) is associated with acute kidney injury (AKI) in thoracic organ transplantation. However, multiple other factors contribute to AKI development after these procedures such as renal ischemia-reperfusion injury (IRI) due to hypo-perfusion of the kidney during surgery. In this study, we aimed to explore the kidney injury patterns in mouse models of ECMO and renal IRI. Kidneys of C57BL/6 mice were examined after moderate (35 min) and severe (45 min) unilateral transient renal pedicle clamping and 2 h of veno-venous ECMO. Renal injury markers, neutrophil infiltration, tubular transport function, pro-inflammatory cytokines, and renal heme oxygenase-1 (HO-1) expression were determined by immunofluorescence and qPCR. Both procedures caused AKI, but with different injury patterns. Severe neutrophil infiltration of the kidney was evident after renal IRI, but not following ECMO. Tubular transport function was severely impaired after renal IRI, but preserved in the ECMO group. Both procedures caused upregulation of pro-inflammatory cytokines in the renal tissue, but with different time kinetics. After ECMO, but not IRI, HO-1 was strongly induced in tubular cells indicating contact with hemolysis-derived proteins. After IRI, HO-1 was expressed on infiltrating myeloid cells in the tubulo-interstitial space. In conclusion, renal IRI and ECMO both caused AKI, but kidney damage after renal IRI was more pronounced including severe neutrophil infiltration and tubular transport impairment. Enhanced HO-1 expression in tubular cells after ECMO encourages limitation of hemolysis as a therapeutic approach to reduce ECMO-associated AKI.


  • Open Access

    Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation

    by Dejan Radakovic, Kiril Penov, Khaled Hamouda, Nodir Madrahimov, Darko Radakovic, Constanze Bening, Rainer G. Leyh, Ivan Aleksic

    Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential benefits and safety of combining these two devices. Methods: We enrolled 200 patients treated with either VA-ECMO only or in combination with IABP (ECMO-I group) between January 2012 and January 2021. To adjust the patients’ backgrounds, we used propensity score matching for additional analyses, resulting in 57 pairs. The primary endpoint was 30-day survival. Secondary endpoints included successful weaning and complication rates. We also analysed hemodynamic parameters in both groups. Results: After propensity score matching, 30-day survival was better in the ECMO-I group (log-rank p = 0.004). The ECMO-I and ECMO-only groups differed regarding the secondary endpoints, including successful weaning (50.9% and 26.3%, respectively; p = 0.012) and the need for continuous renal replacement therapy (28.1% and 50.9%, p = 0.021). Complication rates were not statistically different between the two groups. Conclusion: Compared to VA-ECMO alone, the combined use of VA-ECMO and IABP is beneficial regarding 30-day survival in selected patients with postcardiotomy shock; successful ECMO weaning and freedom from renal replacement therapy is more common in patients supported with VA-ECMO plus IABP.


  • Primary Graft Dysfunction following Lung Transplantation Is Associated with Increased In Vivo T-Cell Alloreactivity

    by A. K. Knöfel, T. Siemeni, N. Madrahimov, W. Sommer, J. Salman, M. Avsar, C. Kühn, I. Tudorache, A. Haverich, C. Falk, et al.

    Background: Primary graft dysfunction (PGD) is the leading cause of early mortality following lung transplantation (LTx). Here, we investigated the correlation between PGD early after lung transplantation and the subsequent development of transplant atherosclerosis (TA) in a humanized mouse model. Method: The pericardiophrenic artery obtained from human donor lungs was implanted into the aorta of NOD/Rag−/−/IL-2rgc−/− mice reconstituted with either naive or primed allogeneic peripheral blood mononuclear cells (PBMC). These were obtained from the respective lung recipient either before or 21 days after transplantation. Results: Histological assessment after 28 days showed significantly more intimal hyperplasia of arteries in mice reconstituted with PBMC from patients with PGD (score 2 or 3) compared with patients without PGD (score 0 or 1). Enriching of CD4 + CD25 high regulatory T cells (Treg) in PBMC suppressed the development of TA in both PGD groups. TA was similarly suppressed by enriching of naive or alloantigen-primed Treg. Mice transplanted with arteries from donors undergoing PGD score 2 or 3 developed higher CXCL10 (IP-10) serum concentrations. Conclusion: We conclude that both donor tissue inflammation and recipient T cell responses contribute to PGD, eventually triggering rejection. This inflammatory response can be suppressed by early supplementation with Treg cells, indicating a potential target for future early interventions in lung transplantation. Publication Date: 03 February 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Safety and Efficacy of Recombinant Factor VIIa (NovoSeven) Use during ECMO Support in Patients after Cardiac Surgery

    by Natanov R, Madrahimov N, Fleissner F, Mogaldea A, Ruemke S, Haverich A, Kuehn C

    Background: Acute postoperative bleeding in cardiac surgical patients is a major cause of morbidity and mortality. Substitution of coagulatory factors may not always provide optimal hemostasis and off label, use of recombinant FVIIa has been proposed. When on ECMO, extra care must be taken during coagulatory substitution as clotting of the system may cause cardiovascular complications and possible ECMO failure, leading to death. In this paper, we examined the safety and efficacy of rFVIIa during ECMO support in postoperative cardio-surgical patients.

  • Open Access

    Four hours of veno-venous extracorporeal membrane oxygenation using bi-caval cannulation affects kidney function and induces moderate lung damage in a mouse model

    by Ruslan Natanov, Abdurasul Khalikov, Faikah Gueler, Ulrich Maus, Erin C. Boyle, Axel Haverich, Christian Kühn, Nodir Madrahimov

    Background: Improvement of single site cannulation for extracorporeal membrane oxygenation (ECMO) therapy is pivotal for reduction of patient morbidity and mortality in respiratory failure. To further improve the cardiopulmonary outcomes and reduce end organ damage, we established a murine model for single site cannulation with a double lumen cannula. Results: We created a hemodynamically stable double lumen cannula and successfully implanted it through the jugular vein into the upper and lower vena cava. This allowed adequate drainage of the blood. Blood gas analysis showed excellent oxygenation and CO2 reduction. There was no excessive bleeding. No signs of right heart congestion were present which was confirmed in the histological analysis of the liver. Histology demonstrated moderate lung damage and mild acute kidney injury. Neutrophil infiltration was similar in ECMO and sham kidneys. Conclusions: Veno-venous extracorporeal circulation deteriorates kidney function and promotes moderate pulmonary damage.


  • Warming and cooling device using thermoelectric Peltier elements tested on male mice

    by Nodir Madrahimov, Ruslan Natanov, Abdurasul Khalikov, Erin C Boyle, Danny Jonigk, Ann-Katrin Knoefel, Thierry Siemeni, Axel Haverich

    Hypothermia is a treatment strategy for different clinical conditions and an essential part of cardiopulmonary bypass in complex cardiac procedures. Clinically, cooling patients is achieved via a mattress and heat exchanger integrated into a membrane oxygenator connected to a waterbed using a refrigerator system based on volatile and toxic liquids. Peltier elements are known as environmentally friendly thermoelectric generators that enable rapid warming and cooling. In this paper, we describe the construction of a novel device for rapid and precise control of mouse warming and cooling using thermoelectric Peltier elements. Six male BALB/c mice were subjected to deep hypothermia and were rewarmed under full physiological monitoring. After rewarming, all animals were observed for two hours, and pathology was evaluated in several organs. All animals tolerated the rapid cooling process well and remained active after rewarming. Temperature-relevant changes were seen via electrocardiography, with heart-rate patterns showing a strong linear correlation to body temperature. No myocardial ischaemia was seen. However, two animals experienced bradycardic atrial fibrillation which spontaneously converted to normal sinus rhythm during rewarming. No histological damage was seen in the heart, liver, kidney or lungs. Our device can effectively be used for heat shock and hypothermia studies in mice, and we foresee no obstacles for its application to other small rodents such as hamsters and young rats. In comparison to known experimental and clinical methods of hypothermia, our device is environmentally friendly, cost-effective and easy to handle, allowing precise control and maintenance of body temperatures ranging from 18℃ to 42℃.